ImportantUpdates
Mono Pharmacare received a ₹0.02 Cr fine from NSE for inadvertent non-compliance.
Mono Pharmacare LimitedMONOPHARMA · Filed with the exchange
The company implemented corrective steps.
Its Board advised management to strengthen internal compliance to prevent future recurrences.
No comments yet. Be the first.